(Press-News.org) There is an urgent need for new drugs to treat Rett syndrome, a rare and severe neurological disease mainly affecting girls. A bottleneck in drug development for this syndrome is a lack of clarity at the level of preclinical research. Key researchers in this field now tackle this issue, proposing standards and guidelines for Rett syndrome research, in an Open Access review article published on Oct. 31, 2012 in Disease Models & Mechanisms (DMM) at http://dmm.biologists.org/. This "state of the science" assessment serves as a comprehensive resource of all findings and citations related to Rett syndrome.
Rett syndrome is a rare neurological disease that affects girls almost exclusively. Affected children appear to grow and develop normally for the first 6-12 months of life, but then begin to show symptoms including slow development, problems crawling or walking, and diminished eye contact. As the syndrome progresses, affected children show a regression of many skills, with loss of purposeful hand use, speech and basic motor function. Severe cases can experience problems with heart, respiratory and gastrointestinal function. Rett syndrome is extremely difficult on affected girls and their families. Although the disease-causing gene (called MECP2) has been identified, there is no cure, and only limited symptomatic treatments are available. A key to developing new treatments for this devastating disorder is to improve systems and standards at the preclinical research level.
The new review article reports on outcomes from a workshop held in September of 2011 focused on the state of the art in animal studies of Rett syndrome. The workshop was convened by important funders of Rett syndrome research, including the National Institute of Neurological Disorders and Stroke (NINDS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the International Rett Syndrome Foundation (IRSF) and the Rett Syndrome Research Trust (RSRT). Workshop participants included key members of the Rett syndrome research community, including basic scientists, clinicians, and representatives from the National Institutes of Health (NIH), the Food and Drug Administration (FDA), the pharmaceutical industry and private foundations. Several workshop participants contributed to the article, and the corresponding authors are Dr. David Katz (Case Western Reserve University School of Medicine), Dr. Laura Mamounas (National Institute of Neurological Disorders and Stroke) and Dr. Huda Zoghbi (Baylor College of Medicine).
The main aim of the workshop was to identify crucial knowledge gaps in Rett syndrome research at the preclinical level, and to suggest scientific priorities and best practices for the use of animal models in preclinical evaluation of potential new therapeutics. As explained in the new review article, the combination of an urgent need for effective treatments for Rett syndrome, coupled with the availability of good mouse models, is a driving force for studies that can identify and test new drugs. The outcome of the workshop included a set of recommended guidelines for animal studies of Rett syndrome, to ensure that decisions to initiate costly clinical trials will be founded on reliable data that is produced using standardized study design and transparent reporting. Ultimately, the increased level of rigor in animal studies should shorten the time to effective treatments.
###REFERENCE: Katz, D. M., Berger-Sweeney, J. E., Eubanks, J. H., Justice, M. J., Neul, J. L., Pozzo-Miller, L., Blue, M. E., Christian, D., Crawley, J. N., Giustetto, M. et al. (2012). Preclinical research in Rett syndrome: setting the foundation for translational success. Dis. Model. Mech. doi:10.1242/dmm.011007
THIS ARTICLE APPEARS IN DISEASE MODELS & MECHANISMS ON: October 31, 2012. EMBARGOED UNTIL: October 31, 2012, 05:15 HRS EDT (10:15 HRS GMT).
IF REPORTING ON THIS STORY, PLEASE MENTION DISEASE MODELS & MECHANISMS AS THE SOURCE AND CARRY A LINK TO: http://dmm.biologists.org/
This article is posted on this site to give advance access to authorised media who may wish to report on this story. Full attribution is required, and if reporting online, a link to dmm.biologists.com is also required. The story posted here refers to an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms.
About the International Rett Syndrome Foundation.
IRSF is the world's leading private funder of basic, translational and clinical Rett syndrome research, funding over $28M in high-quality, peer-reviewed research grants and programs to date. Annually, IRSF hosts the world's largest gathering of global Rett researchers and clinicians to establish research direction and priorities while exchanging ideas and the most recent information. IRSF is the most comprehensive non-profit organization dedicated to providing thorough and accurate information about Rett syndrome, offering informational and emotional family support, and stimulating research aimed at accelerating treatments and a cure for Rett syndrome and related disorders. IRSF has earned Charity Navigator's most prestigious 4 star rating. To learn more about IRSF and Rett syndrome, visit www.rettsyndrome.org or call IRSF at 1-800-818-RETT (7388).
Settings standards for research into Rett syndrome
2012-10-31
ELSE PRESS RELEASES FROM THIS DATE:
Routine blood test predicts prognosis in aggressive skin cancer
2012-10-31
BOSTON, MA (October 31, 2012)—A routine blood test may help predict survival in patients with an aggressive form of skin cancer known as Merkel cell carcinoma, according to new findings by Fox Chase Cancer Center researchers. The results will be presented on Wednesday, October 31 at the American Society for Radiation Oncology's 54th Annual Meeting.
"With such a fast-growing cancer, we get one question a lot: 'how long do I have?'," says Matthew Johnson, MD, a resident physician in the Department of Radiation Oncology at Fox Chase and lead author on the study. "That's ...
Stars ancient and modern?
2012-10-31
This colourful view of the globular star cluster NGC 6362 was captured by the Wide Field Imager attached to the MPG/ESO 2.2-metre telescope at ESO's La Silla Observatory in Chile. This new picture, along with a new image of the central region from the NASA/ESA Hubble Space Telescope, provide the best view of this little-known cluster ever obtained. Globular clusters are mainly composed of tens of thousands of very ancient stars, but they also contain some stars that look suspiciously young.
Globular star clusters are among the oldest objects in the Universe, and NGC 6362 ...
Higher risk of maternal complications/preterm deliveries for women undergoing multiple cesareans
2012-10-31
The risk of maternal complications and preterm deliveries is significantly higher for women undergoing their fifth or more caesarean section, finds a new study published today (31 October) in BJOG: An International Journal of Obstetrics and Gynaecology.
The study explored the incidence of UK women having Multiple Repeat Caesarean Sections (MRCS), defined as five or more, and the outcomes for them and their babies compared to women having their second to fourth caesarean section.
The researchers, from Imperial College Healthcare NHS Trust and the University of Oxford ...
Stereotactic radiosurgery shows promise for kidney cancer
2012-10-31
CLEVELAND – A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer. This non-invasive treatment technique may represent a potential new non-surgical option for patients with this deadly disease who have limited treatment options.
Rod Ellis, MD, lead author of the study along with Lee Ponsky, MD, who is the Principal Investigator, presented results of a Phase 1 clinical trial in 20 patients with localized primary renal ...
Privately owned genetic databases may hinder diagnosis and bar the way to the arrival of personalized medicine
2012-10-31
In response to the on-line publication by the European Journal of Human Genetics today (Wednesday) of an article by US researchers led by Dr. Robert Cook-Degan, a former member of the US Office of Technology Assessment, showing that Myriad Genetics, providers of the BRCA1/2 genetic test in the US, has amassed vast quantities of clinical data without sharing it, Professor Martina Cornel, chair of the European Society of Human Genetics' Professional and Public Policy committee, said:
"We are very concerned that such important data is being withheld from those who most need ...
Obese dogs at risk of health condition experienced by humans
2012-10-31
Veterinary scientists at the University of Liverpool have found that, like humans, obese dogs can experience metabolic syndrome, a condition that describes multiple health issues that occur in the body at the same time.
The condition occurs when a number of health problems, such as increased blood glucose and increased cholesterol levels, develop together, with the potential to increase the risk of other diseases, such as cardiovascular disease and diabetes.
Although canine obesity is known to cause insulin resistance, mild hypertension, and high blood cholesterol ...
Health inequalities could be reduced by more effective health care, says new study
2012-10-31
Wide differences in death rates from disease still persist throughout England – but effective healthcare can help to reduce these inequalities, a new study has discovered.
Researchers from the University of Leicester led a two-year project funded by the National Institute for Health Research (NIHR) into why differences in death rates from diseases like heart disease, strokes, lung disease and cancers still persist.
They found that age and poverty were among the biggest factors that accounted for the differences – but they also discovered that effective delivery of healthcare ...
Navy oceanographers delve deeper in wave data to improve forecasts
2012-10-31
WASHINGTON--Around the globe, mariners and navies alike have long observed and included weather and sea states in navigational planning when plotting course or developing military strategy. And although forecasting had become an integral function by the start of the 20th century, these predictions were often crude and qualitative.
For the U.S. Navy, the years 1941 through 1946 provided an unusual stimulus to ocean wave research, according to pioneer World War II oceanographer Charles Bates. During this brief five-year period, theory, observation, and prediction of sea, ...
Sustainable cities must look beyond city limits
2012-10-31
City leaders aspiring to transform their cities into models of sustainability must look beyond city limits and include in their calculation the global flow of goods and materials into their realm, argue researchers in the Royal Swedish Academy of Sciences journal Ambio.
Many cities are now developing sustainable strategies to reduce pollution and congestion, improve the quality of life of their citizens, and respond to growing concern about human impact on climate and the environment. But sustainable city initiatives often ignore the environmental footprint from imported ...
New metric to track prosthetic arm progress
2012-10-31
PROVIDENCE, R.I. [Brown University] — Amputees with a new prosthetic arm must learn how to use their device to perform everyday tasks that were once second nature. Taking off a shirt becomes a conscious, multistep effort: grasp the shirt, lift the shirt over the head, pull arms through the sleeves, place the shirt on the table, let go of the shirt.
In the best cases of treatment, patients work with teams of doctors, prosthetists, and therapists to learn how their new limbs can help them regain function and quality of life. But clinicians have had few tools to assess ...